Orthofix Medical (OFIX) Return on Capital Employed (2011 - 2026)

Orthofix Medical has disclosed Return on Capital Employed across 16 years of filings, most recently posting 6.64% for Q1 2026.

• Quarterly Return on Capital Employed rose 794.0% year-over-year to 6.64% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6.64% (up 794.0% YoY) and the FY2025 annual result came in at 11.61%, down 18.0% from the prior year.
• Return on Capital Employed rose to 6.64% in Q1 2026, from 12.13% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 1.0% in Q4 2022 and troughed at 18.54% in Q4 2023.
• A 5-year average of 10.61% and a median of 12.83% in 2024 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2023 — Return on Capital Employed sank 1754 bps — and 2026, when it surged 794 bps.
• Tracing OFIX's Return on Capital Employed over 5 years: stood at 1.0% in 2022, then sank by 1748 bps to 18.54% in 2023, then jumped by 36 bps to 11.89% in 2024, then retreated by 2 bps to 12.13% in 2025, then surged by 45 bps to 6.64% in 2026.
• Business Quant data shows OFIX's Return on Capital Employed at 6.64% in Q1 2026, 12.13% in Q4 2025, and 13.84% in Q3 2025.